J Gynecol Oncol.  2020 Sep;31(5):e64. 10.3802/jgo.2020.31.e64.

Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma

Affiliations
  • 1Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy
  • 2Department of Gynecologic Oncology, National Cancer Institute, Milan, Italy
  • 3Obstetrics and Gynecology Unit, Regina Montis Regalis Hospital, Mondovì, Italy
  • 4Department of Gynecologic Oncology Surgery, Istituto Nazionale Tumori, IRCSS, “Fondazione G. Pascale”, Naples, Italy
  • 5Endoscopica Malzoni - Center for Advanced Endoscopic Gynecological Surgery, Avellino, Italy
  • 6Department of Obstetrics and Gynecology, Spedali Civili, Brescia, Italy
  • 7Department of Biomedicine, University of Basel, Basel, Switzerland

Abstract


Objective
Uterine serous carcinoma (USC) is a rare highly aggressive disease. In the present study, we aimed to investigate the survival implication of the systematic lymphadenectomy in patients who underwent surgery for apparent early-stage USC.
Methods
Consecutive patients with apparent early-stage USC surgically treated at six Italian referral cancer centers were analyzed. A comparison was made between patients who underwent retroperitoneal staging including at least pelvic lymphadenectomy “LND” vs. those who underwent hysterectomy alone “NO-LND”. Baseline, surgical and oncological outcomes were analyzed. Kaplan- Meier curves were calculated for disease-free survival (DFS) and disease-specific survival (DSS). Associations were evaluated with Cox proportional hazard regression and summarized using hazard ratio (HR).
Results
One hundred forty patients were analyzed, 106 LND and 34 NO-LND. NO-LND group (compared to LND group) included older patients (median age, 73 vs.67 years) and with higher comorbidities (median Charlson Comorbidity Index, 6 vs. 5) (p<0.001). No differences in terms of recurrence rate (LND vs. NO-LND, 33.1% vs. 41.4%; p=0.240) were observed. At Cox regression analysis lymphadenectomy did not significantly influence DFS (HR=0.59; 95% confidence interval [CI]=0.32–1.08; p=0.09), and DSS (HR=0.14; 95% CI=0.02–1.21; multivariable analysis p=0.07). Positive node was independently associated with worse DFS (HR=6.22; 95% CI=3.08–12.60; p<0.001) and DSS (HR=5.51; 95% CI=2.31– 13.10; p<0.001), while adjuvant chemotherapy was associated with improved DFS (HR=0.38; 95% CI=0.17–0.86; p=0.02) and age was independently associated with worse DSS (HR=1.07; 95% CI=1.02–1.13; p<0.001).
Conclusions
Although lymphadenectomy did not show survival benefits in patients who underwent surgery for apparent early-stage USC, the presence of lymph node metastasis was the main adverse prognostic factors, supporting the prognostic role of the retroperitoneal staging also in this histological subtype.

Keyword

Gynecology; Lymphadenectomy; Survival; Endometrial Neoplasms; Therapeutics
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr